Zobrazeno 1 - 10
of 863
pro vyhledávání: '"M, Zeidan"'
Autor:
Abdulrahman Alhajahjeh, Lara K. Rotter, Jessica M. Stempel, Alyssa A. Grimshaw, Jan Philipp Bewersdorf, Ondrej Blaha, Tariq Kewan, Nikolai A. Podoltsev, Rory M. Shallis, Lourdes Mendez, Maximilian Stahl, Amer M. Zeidan
Publikováno v:
JCO Global Oncology, Iss 10 (2024)
PURPOSEMost clinical trials are conducted exclusively in high-income countries (HICs), with only a small fraction involving centers from low-middle income countries (LMICs). However, studies evaluating the global distribution of clinical trials in le
Externí odkaz:
https://doaj.org/article/7cf99fbf35d340edaf0a2d0f11b7b88d
Publikováno v:
Therapeutic Advances in Hematology, Vol 15 (2024)
Background: Hypomethylating agents (HMAs) are guideline-recommended treatment for higher-risk myelodysplastic syndromes/neoplasms (MDS). However, a prior survey of patients with MDS reported challenges with intravenous (IV) and subcutaneous (SC) HMA
Externí odkaz:
https://doaj.org/article/242ae770e431480485a506cd2325b6d7
Publikováno v:
Frontiers in Hematology, Vol 3 (2024)
Cancer-related somatic genetic alterations are detectable in the blood of individuals without hematologic malignancy, reflecting the outgrowth of a mutated stem/progenitor cell population, a phenomenon termed clonal hematopoiesis (CH). When accompani
Externí odkaz:
https://doaj.org/article/b64eee5323a5472391b08cf596ab8310
Autor:
Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M. Shallis, Sacchi de Camargo Correia Guilherme, Aaron D. Goldberg, Antoine N. Saliba, Anand Patel, Jan P. Bewersdorf, Adam S. DuVall, Danielle Bradshaw, Yasmin Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M. Zeidan, Vamsi Kota, Mark R. Litzow
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-4 (2024)
Externí odkaz:
https://doaj.org/article/768054ee7a0b494192b71e0f348ee872
Autor:
Mai S. Saleh, Asmaa F. Galal, Sara F. Sallam, Noha A. Mowaad, Hala M. Zeidan, Adel Hashish, Hala R. Elhabashy, Ola A. Heikal
Publikováno v:
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, Vol 60, Iss 1, Pp 1-11 (2024)
Abstract Background The elderly population is suffering from many mental health problems that are aggravated as a matter of age and cognitive decline is a serious one of them. The aim of the present work is to screen the cognitive performance among a
Externí odkaz:
https://doaj.org/article/8800076990e14366971e9fface8e7524
Autor:
Amer M. Zeidan, Jan Philipp Bewersdorf, Vanessa Hasle, Rory M. Shallis, Ethan Thompson, Daniel Lopes de Menezes, Shelonidta Rose, Isaac Boss, Stephanie Halene, Torsten Haferlach, Brian A. Fox
Publikováno v:
Therapeutic Advances in Hematology, Vol 15 (2024)
Background: TP53 mutations are associated with an adverse prognosis in acute myeloid leukemia (AML) and higher-risk myelodysplastic syndromes (HR-MDS). However, the integrated genetic, epigenetic, and immunologic landscape of TP53 -mutated AML/HR-MDS
Externí odkaz:
https://doaj.org/article/607d9f5536614146a1ff9b6d9aed6dd7
Autor:
Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M. Shallis, Emily C. Craver, Zhuo Li, Aaron D. Goldberg, Antoine N. Saliba, Anand Patel, Jan P. Bewersdorf, Adam Duvall, Madelyn Burkart, Danielle Bradshaw, Yasmin Abaza, Maximilian Stahl, Neil Palmisiano, Guru Subramanian Guru Murthy, Amer M. Zeidan, Vamsi Kota, Mrinal M. Patnaik, Mark R. Litzow
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
While there is clear evidence to suggest poorer outcome associated with multi-hit (MH) TP53 mutation compared to single-hit (SH) in lower-risk myelodysplastic syndrome (MDS), data are conflicting in both higher-risk MDS and acute myeloid leukemia (AM
Externí odkaz:
https://doaj.org/article/c1694d4dbade4d11b7fd3ea5b5113ad5
Autor:
Fabio Efficace, Rena Buckstein, Gregory A. Abel, Johannes M. Giesinger, Pierre Fenaux, Jan Philipp Bewersdorf, Andrew M. Brunner, Rafael Bejar, Uma Borate, Amy E. DeZern, Peter Greenberg, Gail J. Roboz, Michael R. Savona, Francesco Sparano, Jacqueline Boultwood, Rami Komrokji, David A. Sallman, Zhuoer Xie, Guillermo Sanz, Hetty E. Carraway, Justin Taylor, Stephen D. Nimer, Matteo Giovanni Della Porta, Valeria Santini, Maximilian Stahl, Uwe Platzbecker, Mikkael A. Sekeres, Amer M. Zeidan
Publikováno v:
HemaSphere, Vol 8, Iss 5, Pp n/a-n/a (2024)
Abstract Notable treatment advances have been made in recent years for patients with myelodysplastic syndromes/neoplasms (MDS), and several new drugs are under development. For example, the emerging availability of oral MDS therapies holds the promis
Externí odkaz:
https://doaj.org/article/cf17fd5c0de047b1a6c103df622ef528
Autor:
Haya M. Alogayell, Ahmed Kamal, Ibtesam I. Alkadi, Mona S. Ramadan, Rasha H. Ramadan, Ali M. Zeidan
Publikováno v:
Frontiers in Sustainable Cities, Vol 6 (2024)
This research presents a GIS-based approach to evaluate land suitability for the urbanization of Saudi Arabia’s NEOM region, an ambitious initiative for sustainable development within a desert setting. By employing a multi-criteria decision-making
Externí odkaz:
https://doaj.org/article/7af22984bd0243d18fb1b62e3c4eed3a
Autor:
Nikolai A. Podoltsev, Rong Wang, Rory M. Shallis, Jessica M. Stempel, Mengyang Di, Natalia Neparidze, Amer M. Zeidan, Scott F. Huntington, Smith Giri, Sarah C. Hull, Steven D. Gore, Xiaomei Ma
Publikováno v:
Cancer Medicine, Vol 12, Iss 18, Pp 18889-18900 (2023)
Abstract Background Polycythemia vera (PV) and essential thrombocythemia (ET) are linked to increased risk of cardiovascular morbidity and mortality. In addition to the reduction in of arterial thrombotic events, statins may prevent venous thrombosis
Externí odkaz:
https://doaj.org/article/37b984a3a27e4915a681f12f7319c9f7